f Discovery of Lead Compounds Targeting Transcriptional Regulation

References

1. LiuB. ZhouH. TanL. SiuK.T.H. GuanX.Y. Exploring treatment options in cancer: Tumor treatment strategies.Signal Transduct. Target. Ther.20249117510.1038/s41392‑024‑01856‑7 39013849
   [Google Scholar]
2. ZhongL. LiY. XiongL. WangW. WuM. YuanT. YangW. TianC. MiaoZ. WangT. YangS. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives.Signal Transduct. Target. Ther.20216120110.1038/s41392‑021‑00572‑w 34054126
   [Google Scholar]
3. JiaG. JiangY. LiX. Targeted drug conjugates in cancer therapy: Challenges and opportunities.Pharm. Sci. Adv.2024210004810.1016/j.pscia.2024.100048
   [Google Scholar]
4. BushwellerJ.H. Targeting transcription factors in cancer — From undruggable to reality.Nat. Rev. Cancer2019191161162410.1038/s41568‑019‑0196‑7 31511663
   [Google Scholar]
5. HasanA. KhanN.A. UddinS. KhanA.Q. SteinhoffM. Deregulated transcription factors in the emerging cancer hallmarks.Semin. Cancer Biol.202498315010.1016/j.semcancer.2023.12.001 38123029
   [Google Scholar]
6. ZhuangJ. LiuQ. WuD. TieL. Current strategies and progress for targeting the “undruggable” transcription factors.Acta Pharmacol. Sin.202243102474248110.1038/s41401‑021‑00852‑9 35132191
   [Google Scholar]
7. HenleyM.J. KoehlerA.N. Advances in targeting ‘undruggable’ transcription factors with small molecules.Nat. Rev. Drug Discov.202120966968810.1038/s41573‑021‑00199‑0 34006959
   [Google Scholar]
8. CuiH. StilgenbauerM. KoehlerA.N. Small-molecule approaches to target transcription factors.Annu. Rev. Cancer Biol.20248839541510.1146/annurev‑cancerbio‑062722‑012209
   [Google Scholar]
9. WangX. VanP.K.T. LiuB. ZhaoT. WuY. Targeting the Lin28/let-7 axis with compounds to regulate transcriptional control in cancer.Anticancer. Agents Med. Chem.20252512113610.2174/0118715206375441250901064006 40968436
   [Google Scholar]
10. ChenH. GuanT. SongJ. ChenY. The function of poly (U) binding splicing factor 60 (PUF60) in disease regulation.Anticancer. Agents Med. Chem.20252513714610.2174/0118715206346843241119105519 39773058
    [Google Scholar]
11. HuM. XuC. XuM. HeS. LiuD. Research progress on small molecule inhibitors of MDM2-p53 protein-protein interaction.Anticancer. Agents Med. Chem.20252514716410.2174/0118715206358340250121060830 40017256
    [Google Scholar]
12. ZhangC. YangY. GaoL.X. GanS. LiJ. WangX. ZhouY.B. WangW.L. Synthesis and evaluation of optical properties, SHP2 inhibitory activity, and cellular imaging for novel 2-quinolone derivatives.Anticancer. Agents Med. Chem.20252516517410.2174/0118715206337347250219112715 40103459
    [Google Scholar]